Mishonga Holdings/ Services/ Market access & regulatory strategy
SADC · Africa · Diaspora · Tender · Market Entry

Market access across 15+ countries.

SADC regulatory strategy, distribution structuring, tender management, diaspora market development, and commercial advisory for pharmaceutical and regulated-product businesses entering or expanding across African and global markets.

Request a proposal ↗ Meet Denver
15+
Countries active
50+
Clients served
SADC
Regulatory expertise
30+
Years commercial exp.
Market access services

Every stage of market entry.

Mishonga provides integrated market access advisory — from regulatory pathway mapping and dossier strategy through distribution structuring, tender management, and in-market commercial development.

01
Regulatory pathway mapping
Country-by-country regulatory pathway assessment — authority identification, dossier requirements, timeline modelling, and market prioritisation for pharmaceutical and regulated-product market entry.
Regulatory mappingPathwayTimelineAuthorityDossier
02
SADC regulatory harmonisation
ZaZiBoNa joint review submissions, SADC regulatory harmonisation strategy, and multi-country coordinated registration — reducing the cost and time of multi-market pharmaceutical registration.
ZaZiBoNaSADCHarmonisationJoint reviewMulti-market
03
Distribution structuring
Pharmaceutical and regulated-product distribution partner identification, commercial agreement structuring, GDP compliance review, and supply chain design for African market entry.
DistributionGDPSupply chainPartnersCommercial
04
Tender management
Government tender strategy, bid preparation, pricing analysis, and submission management for pharmaceutical, medical device, and regulated-product tenders across African markets.
TenderGovernmentPricingBidState procurement
05
Diaspora market development
Market entry strategy for pharmaceutical and health product businesses targeting African diaspora markets in Europe, UK, US, and Middle East — regulatory requirements and commercial strategy.
DiasporaEuropeUKUSMarket entryAfrican
06
Pricing & reimbursement strategy
Multi-country pricing strategy, health technology assessment advisory, reimbursement framework navigation, and public sector pricing alignment for regulated products entering African markets.
PricingHTAReimbursementPublic sectorStrategy
Regulatory submissions by country

Country-by-country regulatory experience.

Mishonga has direct experience managing regulatory submissions and market access projects across the following jurisdictions — with established relationships with key authorities and in-country networks.

South Africa
SAHPRA — full service
Complete SAHPRA dossier, pricing, licensing, and market access advisory — Mishonga's home jurisdiction and primary regulatory competency.
SADC
ZaZiBoNa joint review
SADC joint medicines review submissions — coordinated strategy across member states for parallel registration of pharmaceutical products.
East Africa
Kenya, Tanzania, Uganda — EAC
East African Community regulatory submissions — KEBS, TFDA, NDA — coordinated with in-country regulatory counsel for pharmaceutical and health product registration.
West Africa
Ghana, Nigeria — FDAC/NAFDAC
West African regulatory submissions — FDA Ghana and NAFDAC Nigeria — product registration and market entry advisory for pharmaceutical clients.
Europe
EMA, MHRA — EU and UK
EMA centralised and decentralised procedures, MHRA registration — coordinated for African-manufactured products seeking European market access.
Global
FDA, TGA, WHO prequalification
US FDA registration, TGA Australia, and WHO prequalification — for African manufacturers seeking global market access for generic and essential medicines.
Frequently asked

Common questions from clients.

Which African markets does Mishonga have direct regulatory experience in?
Mishonga has direct experience across Southern Africa (South Africa, Lesotho, Botswana, Eswatini, Namibia, Zimbabwe), East Africa (Kenya, Tanzania, Uganda), West Africa (Ghana, Nigeria), and North Africa advisory. For markets where Mishonga has not previously operated, engagements are structured with in-country legal and regulatory counsel managed from South Africa.
Can Mishonga manage the full market entry process, not just regulatory?
Yes. Mishonga's market access practice covers the full entry lifecycle — regulatory pathway mapping, dossier strategy, distribution partner identification, commercial agreement structuring, and tender management. This integrated approach is particularly valuable for clients entering multiple African markets simultaneously.
How does the ZaZiBoNa joint review work?
The SADC Joint Generic Medicines Evaluation (ZaZiBoNa) allows pharmaceutical companies to submit a single dossier for evaluation across multiple SADC member states simultaneously — reducing the cost and time of multi-country registration compared to sequential national submissions. Not all SADC states are full participants, and some products are excluded. Mishonga assesses ZaZiBoNa eligibility and manages the joint submission process.
Can Mishonga assist with government tender submissions?
Yes. Mishonga provides tender strategy, bid preparation, and pricing analysis for government pharmaceutical and regulated-product tenders across African markets — including the South African NHLS, DOH provincial tenders, and key bilateral tenders in SADC markets.

Open new African markets.

Tell us your product, target countries, and timeline — we'll map the regulatory pathway and scope a market entry approach within 48 hours.

Request a proposal → Email Denver directly
© 2026 Mishonga Holdings Pty Ltd · SAPC #14144 South Africa · Africa · Global